Allarity Therapeutics, Inc.
News
Allarity Therapeutics executes 1-for-30 reverse stock split
Seeking Alpha - Healthcare Allarity Therapeutics executes 1-for-30 reverse stock split...\n more…
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)
Globe Newswire Boston (September 11, 2024) Allarity Therapeutics, Inc. ( Allarity or the Company ) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments...\n more…
Short Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Declines By 45.4%
Ticker Report Allarity Therapeutics, Inc. (NASDAQ:ALLR - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 15th, there was short interest totalling 299,300...\n more…
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws
PR Newswire Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws Wolf Haldenstein Adler...\n more…
ALLARITY THERAPEUTICS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Allarity Therapeutics, Inc. (NASDAQ: ALLR), You Are to Contact The Rosen Law Firm About Your Rights
Globe Newswire NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Allarity...\n more…